Clinical trial
NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic…
NCT00293137 · The Cleveland Clinic, Other · Terminated
Key facts
| NCT number | NCT00293137 |
|---|---|
| Title | NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy |
| Official title | Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy |
| Acronym | NORDIC |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Chronic Systolic Heart Failure (Dilated Cardiomyopathy) |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Feb 17, 2006 |
| Last update posted | Sep 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: